Targeting of sonic hedgehog‑Gli signaling: A potential therapeutic target for patients with breast cancer

Song,Lingqin; Wang,Weifeng; Liu,Di; Zhao,Yang; He,Jianjun; Wang,Xijing; Dai,Zhijun; Zhang,Huimin; Li,Xiao

doi:10.3892/ol.2016.4722

Targeting of sonic hedgehog‑Gli signaling: A potential therapeutic target for patients with breast cancer

Authors:
- Lingqin Song
- Weifeng Wang
- Di Liu
- Yang Zhao
- Jianjun He
- Xijing Wang
- Zhijun Dai
- Huimin Zhang
- Xiao Li
View Affiliations

Affiliations: Department of Tumor Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Department of Tumor Surgery, The First People's Hospital of Xianyang, Xianyang, Shaanxi 712000, P.R. China, Department of Tumor Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: June 15, 2016 https://doi.org/10.3892/ol.2016.4722
Pages: 1027-1033

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer is the most common malignant cancer among women. The Hedgehog (Hh) signaling pathway serves a key role in malignant cancer cell growth and migration. However, little is known with regard to the specific function of the Hh signaling pathway in human breast cancer. The current study investigated the specific role of Hh signaling in the human breast cancer cell line MDA‑MB‑231. Expression of components of Shh‑Gli signaling, as well as the Gli‑responsive genes B‑cell lymphoma 2 (Bcl‑2) and cyclin D1, were investigated in MDA‑MB‑231 cells using western blotting. The effects of Shh‑Gli signaling on MDA‑MB‑231 proliferation were analyzed by MTT assay. The role of E‑cadherin in the epithelial‑mesenchymal transition process was determined by western blot while matrix metalloproteinase (MMP)‑9/MMP‑2 secretion was studied by enzyme‑linked immunosorbent assay. The results indicated that Shh‑Gli signaling was activated in MDA‑MB‑231 cells, significantly enhancing cell viability. Overexpression of Gli positively regulated the transcription of Bcl‑2 and cyclin D1 thereby regulating MDA‑MB‑231 cell proliferation and survival. Treatment of MDA‑MB‑231 cells with human sonic hedgehog, n‑terminus for 72 h significantly reduced E‑cadherin protein levels and enhanced secretion of MMP‑9 and MMP‑2. These findings suggest that Shh‑Gli signaling is significantly activated in human breast cancer cells, and is accompanied by enhanced cell viability, proliferation and migration capacities.

View Figures

View References

1	Ingham PW and McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
2	Day TF and Yang Y: Wnt and hedgehog signaling pathways in bone development. J Bone Joint Surg Am. 90(Suppl 1): S19–S24. 2008. View Article : Google Scholar
3	Ruel L, Rodriguez R, Gallet A, Lavenant-Staccini L and Thérond PP: Stability and association of Smoothened, Costal2 and Fused with Cubitus interruptus are regulated by Hedgehog. Nat Cell Biol. 5:907–913. 2003. View Article : Google Scholar : PubMed/NCBI
4	Karlstrom RO, Tyurina OV, Kawakami A, Nishioka N, Talbot WS, Sasaki H and Schier AF: Genetic analysis of zebrafish gli1 and gli2 reveals divergent requirements for gli genes in vertebrate development. Development. 130:1549–1564. 2003. View Article : Google Scholar : PubMed/NCBI
5	Dunaeva M, Michelson P, Kogerman P and Toftgard R: Characterization of the physical interaction of Gli proteins with SUFU proteins. J Biol Chem. 278:5116–5122. 2003. View Article : Google Scholar : PubMed/NCBI
6	Abidi A: Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. Indian J Pharmacol. 46:3–12. 2014. View Article : Google Scholar : PubMed/NCBI
7	Scott MP: Cancer: A twist in a hedgehog's tale. Nature. 425:780–782. 2003. View Article : Google Scholar : PubMed/NCBI
8	Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr and Scott MP: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 272:1668–1671. 1996. View Article : Google Scholar : PubMed/NCBI
9	Cowan R, Hoban P, Kelsey A, Birch JM, Gattamaneni R and Evans DG: The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer. 76:141–145. 1997. View Article : Google Scholar : PubMed/NCBI
10	Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP and Beachy PA: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature. 406:1005–1009. 2000. View Article : Google Scholar : PubMed/NCBI
11	Incardona JP, Gaffield W, Kapur RP and Roelink H: The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development. 125:3553–3562. 1998.PubMed/NCBI
12	Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM and Beachy PA: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 297:1559–1561. 2002. View Article : Google Scholar : PubMed/NCBI
13	Che J, Zhang FZ, Zhao CQ, Hu XD and Fan SJ: Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells. Oncol Lett. 5:1417–1421. 2013.PubMed/NCBI
14	Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, Hui C and Daniel CW: The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol. 238:133–144. 2001. View Article : Google Scholar : PubMed/NCBI
15	Lewis MT: Hedgehog signaling in mouse mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia. 6:53–66. 2001. View Article : Google Scholar : PubMed/NCBI
16	Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, Menon AG, Warren RS, Chen LC, Scott MP and Epstein EH Jr: Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res. 57:2369–2372. 1997.PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Kayed H, Kleeff J, Osman T, Keleg S, Büchler MW and Friess H: Hedgehog signaling in the normal and diseased pancreas. Pancreas. 32:119–129. 2006. View Article : Google Scholar : PubMed/NCBI
19	Zhao L, Yu Y and Deng C: Protein and mRNA expression of Shh, Smo and Gli1 and inhibition by cyclopamine in hepatocytes of rats with chronic fluorosis. Toxicol Lett. 225:318–324. 2014. View Article : Google Scholar : PubMed/NCBI
20	Mistretta CM, Liu HX, Gaffield W and MacCallum DK: Cyclopamine and jervine in embryonic rat tongue cultures demonstrate a role for Shh signaling in taste papilla development and patterning: Fungiform papillae double in number and form in novel locations in dorsal lingual epithelium. Dev Biol. 254:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
21	Chowdhury AK, Ghosh S, Rudin CM, Mukherjee A, Basu A and Dhara S: Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters. PLoS One. 10:e01163902015. View Article : Google Scholar : PubMed/NCBI
22	Ailles L and Siu LL: Targeting the Hedgehog pathway in cancer: Can the spines be smoothened? Clin Cancer Res. 17:2071–2073. 2011. View Article : Google Scholar : PubMed/NCBI
23	Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M: E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
24	Kessenbrock K, Wang CY and Werb Z: Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol. 44–46:184–190. 2015. View Article : Google Scholar
25	Nwabo Kamdje AH, Seke Etet PF, Vecchio L, Muller JM, Krampera M and Lukong KE: Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. Cell Signal. 26:2843–2856. 2014. View Article : Google Scholar : PubMed/NCBI
26	Qiao A, Gu F, Guo X, Zhang X and Fu L: Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications. Front Med. 10:33–40. 2016. View Article : Google Scholar : PubMed/NCBI
27	Hooper JE and Scott MP: Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 6:306–317. 2005. View Article : Google Scholar : PubMed/NCBI
28	Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature. 432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
29	Li Y, Maitah MY, Ahmad A, Kong D, Bao B and Sarkar FH: Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opin Ther Targets. 16:49–66. 2012. View Article : Google Scholar : PubMed/NCBI
30	Di Magno L, Coni S, Di Marcotullio L and Canettieri G: Digging a hole under Hedgehog: Downstream inhibition as an emerging anticancer strategy. Biochim Biophys Acta. 1856:62–72. 2015.PubMed/NCBI
31	Jiang J and Hui CC: Hedgehog signaling in development and cancer. Dev Cell. 15:801–812. 2008. View Article : Google Scholar : PubMed/NCBI
32	Hui M, Cazet A, Nair R, Watkins DN, O'Toole SA and Swarbrick A: The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Res. 15:2032013. View Article : Google Scholar : PubMed/NCBI
33	Kasper M, Regl G, Frischauf AM and Aberger F: GLI transcription factors: Mediators of oncogenic Hedgehog signalling. Eur J Cancer. 42:437–445. 2006. View Article : Google Scholar : PubMed/NCBI
34	Shahi MH, Afzal M, Sinha S, Eberhart CG, Rey JA, Fan X and Castresana JS: Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma. BMC Cancer. 10:6142010. View Article : Google Scholar : PubMed/NCBI
35	Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C, Frischauf AM and Aberger F: Activation of the Bcl2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 64:7724–7731. 2004. View Article : Google Scholar : PubMed/NCBI
36	Joannes A, Grelet S, Duca L, Gilles C, Kileztky C, Dalstein V, Birembaut P, Polette M and Nawrocki-Raby B: Fhit regulates EMT targets through an EGFR/Src/ERK/Slug Signaling axis in human bronchial cells. Mol Cancer Res. 12:775–783. 2014. View Article : Google Scholar : PubMed/NCBI
37	Bailey JM, Mohr AM and Hollingsworth MA: Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene. 28:3513–3525. 2009. View Article : Google Scholar : PubMed/NCBI
38	Qi HW, Xin LY, Xu X, Ji XX and Fan LH: Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transl Med. 12:222014. View Article : Google Scholar : PubMed/NCBI
39	Huang L, Wu RL and Xu AM: Epithelial-mesenchymal transition in gastric cancer. Am J Transl Res. 7:2141–2158. 2015.PubMed/NCBI